Phase II, multicentre, randomised, double blind, placebo controlled pilot study to determine proof of efficacy, safety, tolerability and pharmacokinetics of intravesical PSD597 [lidocaine] in the symptomatic management of interstitial cystitis/painful bladder syndrome

Trial Profile

Phase II, multicentre, randomised, double blind, placebo controlled pilot study to determine proof of efficacy, safety, tolerability and pharmacokinetics of intravesical PSD597 [lidocaine] in the symptomatic management of interstitial cystitis/painful bladder syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Mar 2008

At a glance

  • Drugs Lidocaine (Primary)
  • Indications Bladder disorders; Interstitial cystitis; Pain
  • Focus Therapeutic Use
  • Sponsors Plethora Solutions
  • Most Recent Events

    • 10 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top